Cargando…
Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
Little is known about the role of the neuropeptide somatostatin (SST) in myocardial ischemia/reperfusion injury and cardioprotection. Here, we investigated the direct cardiocytoprotective effect of SST on ischemia/reperfusion injury in cardiomyocyte cultures, as well as the expression of SST and its...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602362/ https://www.ncbi.nlm.nih.gov/pubmed/34803662 http://dx.doi.org/10.3389/fphar.2021.663655 |
_version_ | 1784601563264712704 |
---|---|
author | Vörös, Imre Sághy, Éva Pohóczky, Krisztina Makkos, András Onódi, Zsófia Brenner, Gábor B. Baranyai, Tamás Ágg, Bence Váradi, Barnabás Kemény, Ágnes Leszek, Przemyslaw Görbe, Anikó Varga, Zoltán V. Giricz, Zoltán Schulz, Rainer Helyes, Zsuzsanna Ferdinandy, Péter |
author_facet | Vörös, Imre Sághy, Éva Pohóczky, Krisztina Makkos, András Onódi, Zsófia Brenner, Gábor B. Baranyai, Tamás Ágg, Bence Váradi, Barnabás Kemény, Ágnes Leszek, Przemyslaw Görbe, Anikó Varga, Zoltán V. Giricz, Zoltán Schulz, Rainer Helyes, Zsuzsanna Ferdinandy, Péter |
author_sort | Vörös, Imre |
collection | PubMed |
description | Little is known about the role of the neuropeptide somatostatin (SST) in myocardial ischemia/reperfusion injury and cardioprotection. Here, we investigated the direct cardiocytoprotective effect of SST on ischemia/reperfusion injury in cardiomyocyte cultures, as well as the expression of SST and its receptors in pig and human heart tissues. SST induced a bell-shaped, concentration-dependent cardiocytoprotection in both adult rat primary cardiomyocytes and H9C2 cells subjected to simulated ischemia/reperfusion injury. Furthermore, in a translational porcine closed-chest acute myocardial infarction model, ischemic preconditioning increased plasma SST-like immunoreactivity. Interestingly, SST expression was detectable at the protein, but not at the mRNA level in the pig left ventricles. SSTR1 and SSTR2, but not the other SST receptors, were detectable at the mRNA level by PCR and sequencing in the pig left ventricle. Moreover, remote ischemic conditioning upregulated SSTR1 mRNA. Similarly, SST expression was also detectable in healthy human interventricular septum samples at the protein level. Furthermore, SST-like immunoreactivity decreased in interventricular septum samples of patients with ischemic cardiomyopathy. SSTR1, SSTR2, and SSTR5 but not SST and the other SST receptors were detectable at the mRNA level by sequencing in healthy human left ventricles. In addition, in healthy human left ventricle samples, SSTR1 and SSTR2 mRNAs were expressed especially in vascular endothelial and some other cell types as detected by RNA Scope(®) in situ hybridization. This is the first demonstration that SST exerts a direct cardiocytoprotective effect against simulated ischemia/reperfusion injury. Moreover, SST is expressed in the heart tissue at the peptide level; however, it is likely to be of sensory neural origin since its mRNA is not detectable. SSTR1 and SSTR2 might be involved in the cardioprotective action of SST, but other mechanisms cannot be excluded. |
format | Online Article Text |
id | pubmed-8602362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86023622021-11-20 Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection Vörös, Imre Sághy, Éva Pohóczky, Krisztina Makkos, András Onódi, Zsófia Brenner, Gábor B. Baranyai, Tamás Ágg, Bence Váradi, Barnabás Kemény, Ágnes Leszek, Przemyslaw Görbe, Anikó Varga, Zoltán V. Giricz, Zoltán Schulz, Rainer Helyes, Zsuzsanna Ferdinandy, Péter Front Pharmacol Pharmacology Little is known about the role of the neuropeptide somatostatin (SST) in myocardial ischemia/reperfusion injury and cardioprotection. Here, we investigated the direct cardiocytoprotective effect of SST on ischemia/reperfusion injury in cardiomyocyte cultures, as well as the expression of SST and its receptors in pig and human heart tissues. SST induced a bell-shaped, concentration-dependent cardiocytoprotection in both adult rat primary cardiomyocytes and H9C2 cells subjected to simulated ischemia/reperfusion injury. Furthermore, in a translational porcine closed-chest acute myocardial infarction model, ischemic preconditioning increased plasma SST-like immunoreactivity. Interestingly, SST expression was detectable at the protein, but not at the mRNA level in the pig left ventricles. SSTR1 and SSTR2, but not the other SST receptors, were detectable at the mRNA level by PCR and sequencing in the pig left ventricle. Moreover, remote ischemic conditioning upregulated SSTR1 mRNA. Similarly, SST expression was also detectable in healthy human interventricular septum samples at the protein level. Furthermore, SST-like immunoreactivity decreased in interventricular septum samples of patients with ischemic cardiomyopathy. SSTR1, SSTR2, and SSTR5 but not SST and the other SST receptors were detectable at the mRNA level by sequencing in healthy human left ventricles. In addition, in healthy human left ventricle samples, SSTR1 and SSTR2 mRNAs were expressed especially in vascular endothelial and some other cell types as detected by RNA Scope(®) in situ hybridization. This is the first demonstration that SST exerts a direct cardiocytoprotective effect against simulated ischemia/reperfusion injury. Moreover, SST is expressed in the heart tissue at the peptide level; however, it is likely to be of sensory neural origin since its mRNA is not detectable. SSTR1 and SSTR2 might be involved in the cardioprotective action of SST, but other mechanisms cannot be excluded. Frontiers Media S.A. 2021-11-05 /pmc/articles/PMC8602362/ /pubmed/34803662 http://dx.doi.org/10.3389/fphar.2021.663655 Text en Copyright © 2021 Vörös, Sághy, Pohóczky, Makkos, Onódi, Brenner, Baranyai, Ágg, Váradi, Kemény, Leszek, Görbe, Varga, Giricz, Schulz, Helyes and Ferdinandy. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Vörös, Imre Sághy, Éva Pohóczky, Krisztina Makkos, András Onódi, Zsófia Brenner, Gábor B. Baranyai, Tamás Ágg, Bence Váradi, Barnabás Kemény, Ágnes Leszek, Przemyslaw Görbe, Anikó Varga, Zoltán V. Giricz, Zoltán Schulz, Rainer Helyes, Zsuzsanna Ferdinandy, Péter Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection |
title | Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection |
title_full | Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection |
title_fullStr | Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection |
title_full_unstemmed | Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection |
title_short | Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection |
title_sort | somatostatin and its receptors in myocardial ischemia/reperfusion injury and cardioprotection |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602362/ https://www.ncbi.nlm.nih.gov/pubmed/34803662 http://dx.doi.org/10.3389/fphar.2021.663655 |
work_keys_str_mv | AT vorosimre somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT saghyeva somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT pohoczkykrisztina somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT makkosandras somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT onodizsofia somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT brennergaborb somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT baranyaitamas somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT aggbence somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT varadibarnabas somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT kemenyagnes somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT leszekprzemyslaw somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT gorbeaniko somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT vargazoltanv somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT giriczzoltan somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT schulzrainer somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT helyeszsuzsanna somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection AT ferdinandypeter somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection |